Home › Cystic Fibrosis › NCT07031323

OnTrackCF: Engagement, Feasibility, and Acceptability Study

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Diagnosed with CF
2. 18+ years of age
3. Prescribed a CFTR modulator therapy to be taken twice a day
4. Can speak and read English
5. Have regular access to an iOS or Android tablet or smartphone with internet access.

Exclusion Criteria:

1\) Any situation, in the opinion of the Investigator, that would compromise the safety of the patient or the quality of the data

About the study

This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF).

What is being tested

• OnTrackCF (behavioral)

Sponsor: Boston Children's Hospital · Participants: 60 · Started: Nov 20, 2025

Contact the study team

• Emma M McWilliams, BA · Phone: 617-355-7534
• Callie Bacon, MPH · Phone: 617-919-7696

Official record on ClinicalTrials.gov — NCT07031323

Locations in the U.S.

Conditions

• Cystic Fibrosis

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.